申请人:Hoelzemann Guenter
公开号:US20140142097A1
公开(公告)日:2014-05-22
Compounds of the formula (I) in which R, R
1
and X have the meanings indicated in claim
1
, are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases
公式(I)中R,R1和X具有声明1中指示的含义的化合物是TBK1和IKKε的抑制剂,并可用于治疗癌症和炎症性疾病等。